Uni-Pex Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Delhi, Delhi, India, established in 1999.
1999 Delhi, Delhi, India Active
Last Updated:
Access Report
About Uni-Pex Pharmaceuticals Private Limited

Uni-Pex Pharmaceuticals Private Limited, a active private limited company, was established on 10 March 1999 in Delhi, Delhi, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24231DL1999PTC098759. Registered under ROC Roc Delhi Ii. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹5.00 M.

It upholds a compliant status. Its leadership includes Jagdish Chand Bansal (Director), Madan Lal Bansal (Director). Past directors included Rajesh Bansal. It holds ₹6.75 Cr open charges and ₹20.00 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 801, 8Th Floor, Gopal Heights, Netaji Subhash Place, Pitampura, Delhi, Delhi, 110034.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231DL1999PTC098759

  • Registration Number

    098759

  • Incorporation Date

    10 March 1999

  • Authorized Capital

    ₹5.00 M

  • Paid-Up Capital

    ₹5.00 M

  • ROC Code

    Roc Delhi Ii

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 M
  • Paid Up Capital ₹ 5.00 M
  • Company Age 27 Year, 3 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 6.75 Cr
  • Satisfied Charges ₹ 20.00 Cr
  • Revenue Growth **** 17.78%
  • Profit Growth **** 91.98%
  • Ebitda **** 3393.05%
  • Net Worth 8.97%
  • Total Assets **** 29.51%
Company report

Uni-Pex Pharmaceuticals Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Uni-Pex Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Uni-Pex Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Jagdish Chand Bansal Director 10 Mar 1999 Current
Madan Lal Bansal Director 10 Mar 1999 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 05 Oct 2009 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Uni-Pex Pharmaceuticals.

Uni-Pex Pharmaceuticals Private Limited, for the financial year ended 2025, experienced significant growth in revenue, with a 17.78% increase. The company also saw a substantial improvement in profitability, with a 91.98% increase in profit. The company's net worth moved up by a moderate rise of 8.97%.

Uni-Pex Pharmaceuticals revenue growth over time
Uni-Pex Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 17.78%
*******
*******
*******
*******
Revenue from Operations
*******
 19.23%
*******
*******
*******
*******
Total Assets
*******
 29.51%
*******
*******
*******
*******
Profit or Loss
*******
 91.98%
*******
*******
*******
*******
Net Worth
*******
 8.97%
*******
*******
*******
*******
EBITDA
*******
 3393.05%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Uni-Pex Pharmaceuticals?

In 2024, Uni-Pex Pharmaceuticals had a public holding of 27.67%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹67,500,000.00

Satisfied Charges

₹200,000,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 6.75 Cr
Latest Charge Details
Date Lender Amount Status
29 Jan 2026 Hdfc Bank Limited ₹5.00 Cr Open
23 Nov 2021 Hdfc Bank Limited ₹1.75 Cr Open
14 Sep 2022 Hdfc Bank Limited ₹20.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Uni-Pex Pharmaceuticals?

Unlock and access historical data on people associated with Uni-Pex Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Uni-Pex Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Uni-Pex Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Uni-Pex Pharmaceuticals
Recent Activity within the Organization
  • Charges

    Progress on A charge with Hdfc Bank Limited amounted to Rs. 50.00 M with Charge ID 101234727 was registered on 29 Jan 2026. was documented.

  • Annual General Meeting

    Progress on Uni-Pex Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Uni-Pex Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii. was recorded as a recent event.

  • Charges

    Progress on A charge registered on 14 Sep 2022 via Charge ID 100621504 with Hdfc Bank Limited was fully satisfied on 02 Sep 2024. was documented.

  • Charges

    Progress on A charge with Hdfc Bank Limited amounted to Rs. 200.00 M with Charge ID 100621504 was registered on 14 Sep 2022. was documented.

  • Charges

    The activity A charge with Hdfc Bank Limited amounted to Rs. 17.50 M with Charge ID 100531614 was registered on 23 Nov 2021. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Uni-Pex Pharmaceuticals Private Limited?

The CIN of Uni-Pex Pharmaceuticals Private Limited is U24231DL1999PTC098759.

Where is Uni-Pex Pharmaceuticals Private Limited headquartered?

Uni-Pex Pharmaceuticals Private Limited is headquartered at 801, 8Th Floor, Gopal Heights, Netaji Subhash Place, Pitampura, Delhi, Delhi, 110034.

When was Uni-Pex Pharmaceuticals Private Limited incorporated?

Uni-Pex Pharmaceuticals Private Limited was incorporated on 10 March 1999.

Who are the current directors of Uni-Pex Pharmaceuticals Private Limited?

The current directors of Uni-Pex Pharmaceuticals Private Limited are

What is the primary industry of Uni-Pex Pharmaceuticals Private Limited?

The primary industry of Uni-Pex Pharmaceuticals Private Limited is Trade.

Is Uni-Pex Pharmaceuticals Private Limited a listed company?

Uni-Pex Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Uni-Pex Pharmaceuticals Private Limited?

The authorized capital of Uni-Pex Pharmaceuticals Private Limited is ₹5.00 M, and the paid-up capital is ₹5.00 M.

What is the compliance status of Uni-Pex Pharmaceuticals Private Limited?

The compliance status of Uni-Pex Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available